U.S. RESEARCH ROUNDUP-Bark, Fleetcor Technologies, Tesla

Reuters
2024-03-05

March 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Bark, Fleetcor Technologies and Tesla, on Tuesday.

HIGHLIGHTS

* Bark Inc : Jefferies raises to buy from hold; raises PT to $1.9 from $1.54

* Fleetcor Technologies Inc : Baird raises to outperform rating

* Tesla Inc : RBC raises target price to $298 from $297

Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.

* Akero Therapeutics Inc : Evercore ISI raises target price to $50 from $36

* Akoya Biosciences Inc : JP Morgan cuts target price to $10 from $12

* Ameresco Inc : Piper Sandler cuts target price to $32 from $42

* Amphastar Pharmaceuticals Inc : JP Morgan initiates with overweight rating; PT $60

* Apellis Pharmaceuticals Inc : JP Morgan raises target price to $79 from $78

* Api Group Corp : JP Morgan raises target price to $35 from $31

* Avidity Biosciences Inc : Leerink Partners raises target price to $38 from $18

* Bark Inc : Jefferies raises to buy from hold; raises PT to $1.9 from $1.54

* Bluebird Bio Inc : HSBC cuts target price to $1.02 from $2.31

* C4 Therapeutics Inc : Jefferies raises target price to $14 from $11

* Cheniere Energy Partners LP : RBC cuts target price to $54 from $61

* Cogent Communications Holdings Inc : JP Morgan cuts target price to $73 from $74

* Costco Wholesale Corp : Oppenheimer raises target price to $805 from $760

* Fleetcor Technologies Inc : Baird raises target price to $330 from $325

* Fleetcor Technologies Inc : Baird raises to outperform rating

* Gitlab Inc : D.A. Davidson cuts target price to $65 from $75

* Gitlab Inc : TD Cowen cuts target price to $76 from $80

* Henry Schein Inc : JP Morgan raises target price to $88 from $82

* Hilton Grand Vacations Inc : Jefferies raises target price to $54 from $50

* Hims & Hers Health Inc : Jefferies raises target price to $17 from $12

* Installed Building Products Inc : D.A. Davidson initiates coverage with buy rating

* Installed Building Products Inc : D.A. Davidson initiates coverage with PT $275

* Metagenomi Inc : JP Morgan initiates coverage with overweight rating

* Metagenomi Inc : JP Morgan initiates coverage with price target $16

* Metagenomi Technologies Llc : Jefferies initiates with buy rating

* Metagenomi Technologies Llc : Jefferies initiates with price target $23

* Natera Inc : Stephens raises target price to $104 from $78

* Nuvalent Inc : JP Morgan raises target price to $98 from $68

* Paccar Inc : JP Morgan raises target price to $135 from $116

* Patterson Companies Inc : JP Morgan cuts target price to $30 from $31

* Paymentus Holdings Inc : JP Morgan raises target price to $19 from $17

* Pennant Group Inc : Stephens raises target price to $22 from $21

* Planet Fitness Inc : RBC raises target price to $80 from $74

* Privia Health Group Inc : JP Morgan cuts target price to $30 from $38

* Springworks Therapeutics Inc : JP Morgan raises target price to $75 from $74

* Squarespace Inc : Baird raises target price to $39 from $30

* Squarespace Inc : Baird raises to outperform rating

* Stitch Fix Inc : Canaccord Genuity cuts target price to $3.5 from $4

* Stitch Fix Inc : Piper Sandler cuts target price to $2.25 from $3

* Stitch Fix Inc : Wedbush cuts target price to $3 from $4

* Tesla Inc : RBC raises target price to $298 from $297

* Topbuild Corp : D.A. Davidson initiates coverage with buy rating; PT $470

* UnitedHealth Group Inc : Stephens cuts target price to $570 from $605

* Viant Technology Inc : Canaccord Genuity raises target price to $10 from $8

* WW Grainger Inc : Oppenheimer raises target price to $1125 from $1075

* Xponential Fitness Inc : Stifel raises target price to $20 from $18

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10